The Board of Directors of Jinyu Bio-technology Co., Ltd. has authorized a buyback plan on April 7, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.87 CNY | +1.18% |
|
-4.72% | -36.21% |
06-18 | Jinyu Bio-Technology's Unit Gets Nod to Produce Triple Cat Vaccine | MT |
05-28 | China Issues Temporary Approval for Jinyu's Inactivated Bovine Nodular Dermatosis Vaccine | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.21% | 1.06B | |
-11.35% | 79.83B | |
-4.56% | 7.03B | |
+21.00% | 3.57B | |
+0.42% | 3.27B | |
-7.81% | 1.21B | |
-38.70% | 1.02B | |
-32.68% | 877M | |
-18.12% | 854M | |
-7.64% | 852M |
- Stock Market
- Equities
- 600201 Stock
- News Jinyu Bio-technology Co., Ltd.
- Jinyu Bio-technology Co., Ltd. authorizes a Buyback Plan.